Vivos Therapeutics to Report 2025 Results and Outline Growth Strategy | VVOS

Apr 15, 2026

Vivos Therapeutics (NASDAQ: VVOS) is set to release its full-year 2025 financial results, accompanied by a management conference call to discuss performance and future outlook. The update is expected to provide key insights into the company’s evolving business model and operational progress.

Following strategic expansion into sleep center acquisitions and partnerships, Vivos is positioning itself to capitalize on growing global demand for sleep health solutions. Investors will be closely watching for updates on revenue growth, cost structure, and scalability as the company continues to build momentum.

#VivosTherapeutics
#VVOS
#Earnings
#FinancialResults
#Healthcare
#SleepApnea
#MedicalDevices
#DigitalHealth
#Biotech
#InvestorRelations
#BusinessGrowth
#HealthcareInnovation
#StockMarket
#AnnaBerry
#NewsOut